Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Vertiv Holdings (VRT) Stock on November 29, 2025: Institutional Moves, Insider Selling and AI Data Center Tailwinds

Vertiv Holdings (VRT) Stock on November 29, 2025: Institutional Moves, Insider Selling and AI Data Center Tailwinds

Vertiv Holdings Co (NYSE: VRT) remains one of the most closely watched “picks‑and‑shovels” stocks in the artificial intelligence (AI) data center boom. After a powerful rebound week, Vertiv shares finished trading on Friday, November 28, 2025 at $179.73, up 4.48%
Roblox (RBLX) Stock on November 29, 2025: Heavy Insider Selling, Big Institutional Buying and New Safety Rules Collide

Roblox (RBLX) Stock on November 29, 2025: Heavy Insider Selling, Big Institutional Buying and New Safety Rules Collide

Published: November 29, 2025 Roblox Corporation’s stock is ending November in a strange spot: Wall Street is broadly bullish, big institutions are still piling in, but insiders have been selling aggressively and regulators are circling the Roblox platform. As of
Constellation Energy (CEG) Stock: Latest News on DOE Loan, Calpine Deal and AI Power Boom — November 29, 2025

Constellation Energy (CEG) Stock: Latest News on DOE Loan, Calpine Deal and AI Power Boom — November 29, 2025

BALTIMORE — Constellation Energy Corporation (NASDAQ: CEG) remains one of Wall Street’s most-watched utility names as of Saturday, November 29, 2025, with its share price hovering just below record highs and a stack of fresh catalysts: a $1 billion U.S.
ImmunityBio (IBRX) Stock Soars After Q3 Revenue Explosion – Can the Rally Survive a Going‑Concern Warning?

ImmunityBio (IBRX) Stock Soars After Q3 Revenue Explosion – Can the Rally Survive a Going‑Concern Warning?

Published: November 29, 2025 ImmunityBio, Inc. (NASDAQ: IBRX) has jumped back onto traders’ and long‑term investors’ radar after a powerful late‑November rally in its share price, driven by blockbuster third‑quarter numbers for its cancer drug Anktiva and a wave of
1 179 180 181 182 183 214
Go toTop